Paushak
- Market cap
- ₹ 1,535 Cr.
- P/E
- 32x
- P/B
- 3.29x
- 52-week range
- 342.5 – 881.95
- ROE
- 7%
- ROCE
- 8%
- Dividend yield
- 0.4%
- Debt / equity
- 0.16
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
About
Paushak Limited is an India-based company, which is engaged in the business of specialty chemicals. The Company is engaged in the business of manufacturing phosgene-based specialty chemicals. Its product categories include chloroformate, isocyanate, chloride, carbonate/carbamate, and others. Its chloroformate products include benzyl chloroformate, ethyl chloroformate, methyl chloroformate, and myristyl chloroformate. The Company's isocyanate products include 2-chloro ethyl isocyanate, phenyl isocyanate, and stearyl isocyanate. Its chloride products include 3 chloropropionyl chloride, diethyl carbamoyl chloride, and dimethyl carbamoyl chloride. The Company's carbonate/carbamate products include polyquaternium, chloromethyl isopropyl carbonate, and bis-(4 nitrophenyl) carbonate. Its other products include tetrabutyl urea, vilsmeier reagent, and dicyclohexyl carbodiimide. It serves various industries, such as pharmaceuticals, agrochemicals, performance, and custom synthesis.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Paushak against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)32 against a typical 25.8: pricier than most peers (1st = cheapest).79th of 129
- Sales growth+50.8% against a typical +25.9% from a year earlier.22nd of 112
- Profit growth+55.6% against a typical +42.4% from a year earlier.46th of 102
- Share price, 3 months+1.5% against a typical −2.7%.49th of 118
- Size₹ 1,534.8 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).39th of 126
Latest announcements
Exchange filings and their impact on the company.
- Q2 revenue +52% and PAT +57% YoY confirms step-change from new capacity, putting FY27 on track for ~50% growth.
Paushak reported Q2 FY27 revenue of Rs 89.32 crore, up 52% from Rs 58.78 crore last year, and net profit of Rs 13.51 crore, up 57%. For the first half, revenue was Rs 172.87 crore and profit was Rs 28.62 crore, already about three-quarters of last full year's totals. The jump follows the commissioning of large new capacity, with margins holding near 29-30% despite higher depreciation and interest, while borrowings fell and operating cash flow stayed strong.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A by CRISIL- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil A | Stable | 15 Jan 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 15 Jan 2026 | Rating action | Crisil A | — | CRISIL | ₹ 145 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 16 Oct 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2026 and other business matters |
| 30 Jul 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 5 May 2026 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters |
| 27 Jan 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 52 | 54 | 52 | 57 | 49 | 52 | 56 | 59 | 49 | 55 | 84 | 89 |
| Expenses | 33 | 35 | 40 | 40 | 35 | 36 | 38 | 44 | 37 | 38 | 58 | 63 |
| Operating Profit | 19 | 19 | 12 | 17 | 15 | 16 | 18 | 15 | 11 | 17 | 26 | 26 |
| OPM % | 36% | 35% | 23% | 30% | 30% | 30% | 32% | 25% | 23% | 30% | 31% | 30% |
| Other Income | 3 | 7 | 4 | 4 | 6 | 0 | 2 | 1 | 1 | 8 | 3 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 8 | 8 | 8 |
| Profit before tax | 18 | 23 | 12 | 17 | 17 | 12 | 16 | 11 | 7 | 16 | 19 | 19 |
| Tax % | 26% | 19% | 17% | 16% | 11% | 21% | 23% | 24% | 17% | 22% | 21% | 27% |
| Net Profit | 14 | 18 | 10 | 14 | 15 | 10 | 12 | 9 | 6 | 13 | 15 | 14 |
| EPS in Rs | 5.54 | 7.42 | 4.19 | 5.77 | 6.2 | 3.9 | 4.89 | 3.5 | 2.5 | 5.07 | 6.12 | 5.48 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 11%
- 5 Years
- 9%
- 3 Years
- 1%
- TTM
- 28%
- 10 Years
- 11%
- 5 Years
- −1%
- 3 Years
- −13%
- TTM
- 4%
- 10 Years
- 24%
- 5 Years
- −12%
- 3 Years
- −4%
- TTM
- —
- 10 Years
- 13%
- 5 Years
- 11%
- 3 Years
- 10%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Paushak | ₹ 613.90 | ₹ 1,535 Cr. | 32x | 3.3x | 7% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 102.6x | 27.4x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.5x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 108.7x | 14x | 13.6% | 21.7% |
Management
- Kirti Shah
- Chief Financial Officer
- Sagar Gandhi
- Compliance Officer, Company Secretary
- Jain Parkash
- Whole-time Director
Prices are delayed and for information only. Nothing on this page is investment advice.